The FDA reminded companies that compounded drugs cannot be marketed with false or misleading claims, including suggesting they are FDA-approved, equivalent to approved products, or sourced from FDA-approved facilities
Also, a phase 3b trial was conducted to investigate the efficacy and safety of semaglutide as add-on to therapy with sodium glucose cotransporter 2 (SGLT2) inhibitor
For muscle preservation, the data is too limited for definitive conclusions, but the additional glucagon component theoretically favors retatrutide through increased thermogenesis and preferential fat mobilization
Delayed gastric emptying slows the entire digestive tract, reducing bowel movement frequency
Alzheimer's & the Nun Study(00:52:34) Exercise & Hippocampal Volume, Falls & Balance(00:57:14) SuperAgers & Athletes
PH: A significant part of your teams mandate centers on innovation